Al Said S, Patel SM, Giugliano RP, Morrow DA, et al. Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial. Circulation 2025 Jun 23. doi: 10.1161/CIRCULATIONAHA.125.074037.
PMID: 40546068